3.
4.
5.
6.
7.
8.
Gelder ICV, Groenveld HF, Crijins HJGM, Tuininga YS, Tijssen IGP, Alings AM et
al. Lenient versus Strict Rate Control in patients with atrial fibrillation (RACE). N
Engl J Med. 2010;362:1363-73.
Carlsson J, Miketic S, Windeler J, Cuneo A, Haun S, Micus S et al. Randomized
trial of rate-control versus rhythm-control in persistent atrial fibrillation: the
Strategies of Treatment of Atrial Fibrillation (STAF) study. J AM Coll Cardiol.
2003;41(10):1690-6.
Diretrizes Brasileiras de Fibrilação Atrial. Arq Bras Cardiol 2009;92(6 supl. 1):1-39.
Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ.
Validation of clinical classification schemes for predicting stroke: results from the
National Registry of Atrial Fibrillation. JAMA 2001;285:2864-70.
Lip GYH, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk
stratification for predicting stroke and thromboembolism in atrial fibrillation using a
novel risk fator-based approach: The Euro Heart Survey on Atrial Fibrillation. Chest.
2010;137:263-72.
Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJ, Lip GY. A novel user-
friendly score (HAS-BLED) to assess one-year risk of major bleeding in atrial
fibrillation patients: The Euro Heart Survey. Chest 2010;138(5):1093-100.BIBLIOGRAFIA
Anderson JL, Halperin JL, Albert NM, Bozkurt B, Brindis RG, Curtis LH et al.
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC
and 2011 ACCF/AHA/HRS recommendations): a report of the American College of
Cardiology/American Heart Association Task Force on Practice Guidelines. J Am
Coll Cardiol. 2013;61(18):1935-44.
Baliga, RR. McGraw-Hill Specialty Board Review Cardiology. Nova York: McGraw-Hill;
2011.
Bennett DH. Cardiac arrhythmias: practical notes on interpretation and treatment. 7. ed.
Hodder Arnold; 2010.
Canham RM. Atrial fibrillation. In: Cuculich PS, Kates AM, Henderson KE, De Fer TM,
editors. The Washington manual: cardiology subspecialty consult. 2. ed. Filadélfia:
Lippincott Williams & Wilkins; 2008.
Lane DA, Lip GYH. Use of the CHA2DS2-VASc and HAS-BLED scores to aid decision
making for thromboprophylaxis in nonvalvular atrial fibrillation. Circulation.
2012;126:860-5.
Lip GYH, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score
for predicting bleeding risk in anticoagulated patients with atrial fibrillation. J Am Coll